Scher HI - Search Results

1

NF-kappaB regulates androgen receptor expression and prostate cancer growth.

Zhang L, Altuwaijri S, Deng F, Chen L, Lal P, Bhanot UK, Korets R, Wenske S, Lilja HG, Chang C, Scher HI, Gerald WL. Zhang L, et al. Among authors: scher hi. Am J Pathol. 2009 Aug;175(2):489-99. doi: 10.2353/ajpath.2009.080727. Epub 2009 Jul 23. Am J Pathol. 2009. PMID: 19628766 Free PMC article.

2

Prostatic cancer: where do we go from here?

Scher H. Scher H. Curr Opin Oncol. 1991 Jun;3(3):568-74. Curr Opin Oncol. 1991. PMID: 1892925 Review.

3

Expression of transforming growth factor-alpha and the epidermal growth factor receptor in human prostate tissues.

Cohen DW, Simak R, Fair WR, Melamed J, Scher HI, Cordon-Cardo C. Cohen DW, et al. Among authors: scher hi. J Urol. 1994 Dec;152(6 Pt 1):2120-4. doi: 10.1016/s0022-5347(17)32335-2. J Urol. 1994. PMID: 7525998

4

Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications.

Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, Zhang ZF, Rosai J. Ghossein RA, et al. Among authors: scher hi. J Clin Oncol. 1995 May;13(5):1195-200. doi: 10.1200/JCO.1995.13.5.1195. J Clin Oncol. 1995. PMID: 7537803

5

Introduction: prostate cancer.

Scher HI. Scher HI. Semin Oncol. 1994 Oct;21(5):511-3. Semin Oncol. 1994. PMID: 7939744 No abstract available.

6

Incorporating tumor biology into therapy for prostate cancer.

Bromberg J, Scher HI. Bromberg J, et al. Among authors: scher hi. Curr Opin Oncol. 1993 May;5(3):546-58. doi: 10.1097/00001622-199305000-00017. Curr Opin Oncol. 1993. PMID: 8494915 Review.

7

Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 and induces G1 arrest in prostatic cancer cell line DU145.

Peng D, Fan Z, Lu Y, DeBlasio T, Scher H, Mendelsohn J. Peng D, et al. Cancer Res. 1996 Aug 15;56(16):3666-9. Cancer Res. 1996. PMID: 8706005

8

Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression.

Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, Finstad CL, Reuter VE, Powell CT, Scheinberg D, Magill C, Scher HI, Albino AP, Nanus DM. Papandreou CN, et al. Among authors: scher hi. Nat Med. 1998 Jan;4(1):50-7. doi: 10.1038/nm0198-050. Nat Med. 1998. PMID: 9427606

9

Positron emission tomography of a human prostate cancer xenograft: association of changes in deoxyglucose accumulation with other measures of outcome following androgen withdrawal.

Agus DB, Golde DW, Sgouros G, Ballangrud A, Cordon-Cardo C, Scher HI. Agus DB, et al. Among authors: scher hi. Cancer Res. 1998 Jul 15;58(14):3009-14. Cancer Res. 1998. PMID: 9679964

10

Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.

Lee CT, Capodieci P, Osman I, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C. Lee CT, et al. Among authors: scher hi. Clin Cancer Res. 1999 May;5(5):977-83. Clin Cancer Res. 1999. PMID: 10353729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

697 results

Search Page

Filters